Straumann Holding AG (OTCMKTS:SAUHY) Short Interest Update

Straumann Holding AG (OTCMKTS:SAUHY) saw a large increase in short interest during the month of August. As of August 31st, there was short interest totaling 4,471 shares, an increase of 346.7% from the August 15th total of 1,001 shares. Currently, 0.0% of the company’s shares are short sold. Based on an average trading volume of 81,714 shares, the days-to-cover ratio is currently 0.1 days.

Straumann Stock Performance

OTCMKTS SAUHY opened at $11.46 on Friday. The company has a 50 day moving average of $12.22 and a 200-day moving average of $11.61. Straumann has a 1-year low of $9.44 and a 1-year high of $13.61.

Analysts Set New Price Targets

Several research analysts have weighed in on SAUHY shares. BMO Capital Markets assumed coverage on Straumann in a report on Wednesday, July 8th. They set an “outperform” rating on the stock. UBS Group upgraded shares of Straumann from a “neutral” rating to a “buy” rating in a report on Tuesday, September 1st. Citigroup reissued a “sell” rating on shares of Straumann in a research report on Thursday, July 9th. Morgan Stanley reissued an “underweight” rating on shares of Straumann in a research report on Tuesday, June 30th. Finally, Barclays reissued an “overweight” rating on shares of Straumann in a report on Thursday, June 18th. Three analysts have rated the stock with a Buy rating, two have given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, Straumann has an average rating of “Hold”.

Straumann Company Profile

Straumann Group is a Switzerland-based dental technology company that develops, manufactures and distributes products used in implant, restorative and orthodontic dentistry. Its portfolio includes dental implants, prosthetic components, biomaterials, digital dentistry systems, clear aligners and related instruments and services.

The company serves dental professionals, laboratories and patients through brands including Straumann, Neodent, ClearCorrect and Medentika. Its solutions are used in tooth replacement, oral tissue regeneration, orthodontic treatment and digitally integrated dental workflows.

Founded in 1954, Straumann has expanded from its Swiss origins into a global business serving customers across Europe, North America, Latin America, Asia-Pacific and other international markets.